alexa Mouse Models As Drivers In Defining New Targets For Therapies-Examples From Prostate Cancer Melanoma Studies
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd World Congress on Cancer Science & Therapy
October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

Ze?ev Ronai
ScientificTracks: J Cancer Sci Ther
DOI: 10.4172/1948-5956.S1.028
Abstract
Prostate adenocarcinomas (PCa) with neuroendocrine (NE) phenotype and NE prostate tumors are associated with poor prognosis and androgen independence. Using a TRAMP::Siah2 -/- genetic mouse model we found that formation of NE tumors and metastasis of PCa requires the ubiquitin ligase Siah2. Siah2 enables cooperation between HIF-1 α and the NE-specific transcription factor FoxA2. Genes induced by HIF-1 α /FoxA2 cooperation are expressed in NE lesions and in metastatic human PCa and are required for formation of the NE phenotype, for metastasis of human PCa as for the development of NE tumors. Inhibition of Siah2 ligases or partial attenuation of HIF1a, or its cooperation with FoxA2, offers new therapeutic modalities for these more aggressive forms of PCa. Using a genetic Braf V600E ::Pten -/- melanoma model, we recently established the importance of phosphoinositide-dependent kinase-1 (PDK-1) for melanoma development and metastasis. PDK-1 is a serine/threonine protein kinase that phosphorylates members of the conserved AGC kinase superfamily, including AKT and PKC. Selective inactivation of Pdk1 in the melanocytes of BrafV 600E ::Pten -/- or Braf V600E ::Cdkn2a -/- ::Pten -/- mice delayed the development of pigmented lesions and melanoma induced by systemic or local administration of 4-HT. Melanoma invasion and metastasis were significantly reduced or completely prevented by Pdk1 deletion. PDK-1 inhibitor GSK2334470 (PDKi) effectively delayed melanomagenesis and metastasis. These studies provide direct genetic evidence for the importance of PDK1in melanoma development and progression and the rationale for targeting this pathway with corresponding inhibitors.
Biography
Ze?ev Ronai graduated (Ph.D., tumor immunology) from the Hebrew University in Jerusalem Israel, followed by postdoctoral training at Columbia University NYC. In 2004, his laboratory moved from Mount Sinai School of Medicine (NYC) to the Sanford-Burnham Medical Research Institute (La Jolla, CA), where he is the Scientific Director of the La Jolla Campus and the Deputy Director for the NCI-designated cancer center. He authored over 250 peer-reviewed papers in the field of signal transduction pathways that underlie melanoma and prostate cancer development. He has been studying ubiquitin ligases (Siah, RNF5), kinases (JNK, PDK1) and the transcription factor ATF2.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version